Heather Allison Boyd1, Saima Basit2, Ida Behrens2, Elisabeth Leirgul2, Henning Bundgaard2, Jan Wohlfahrt2, Mads Melbye2, Nina Øyen2. 1. From Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark (H.A.B., S.B., I.B., J.W., M.M.); Department of Global Public Health and Primary Care, University of Bergen, Norway (E.L., N.Ø.); Department of Cardiology (E.L.) and Center for Medical Genetics and Molecular Medicine (N.Ø.), Haukeland University Hospital, Bergen, Norway; Unit for Inherited Cardiac Diseases, Heart Centre, Copenhagen University Hospital (Rigshospitalet), Denmark (H.B.); Department of Clinical Medicine, Copenhagen University, Denmark (M.M.); and Department of Medicine, Stanford University School of Medicine, CA (M.M.). hoy@ssi.dk. 2. From Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark (H.A.B., S.B., I.B., J.W., M.M.); Department of Global Public Health and Primary Care, University of Bergen, Norway (E.L., N.Ø.); Department of Cardiology (E.L.) and Center for Medical Genetics and Molecular Medicine (N.Ø.), Haukeland University Hospital, Bergen, Norway; Unit for Inherited Cardiac Diseases, Heart Centre, Copenhagen University Hospital (Rigshospitalet), Denmark (H.B.); Department of Clinical Medicine, Copenhagen University, Denmark (M.M.); and Department of Medicine, Stanford University School of Medicine, CA (M.M.).
Abstract
BACKGROUND: Both pregnant women carrying fetuses with heart defects and women with hypertensive disorders of pregnancy often exhibit angiogenic imbalances, suggesting that the same mechanisms are involved in the pathogenesis of the former and the pathophysiology of the latter. We conducted a register-based cohort study to determine whether offspring congenital heart defects are associated with an increased risk of hypertensive disorders of pregnancy and whether the mechanisms driving any association are primarily maternal or fetal. METHODS: Among singleton pregnancies without chromosomal abnormalities lasting ≥20 weeks in Denmark from 1978 to 2011 (n= 1 972 857), we identified pregnancies complicated by offspring congenital heart defects or early preterm preeclampsia, late preterm preeclampsia, term preeclampsia, and gestational hypertension. We used polytomous logistic regression to estimate odds ratios (ORs) for associations between offspring congenital heart defects and maternal hypertensive disorders of pregnancy overall and for specific heart defects. RESULTS: Offspring congenital heart defects were strongly associated with early preterm preeclampsia (OR, 7.00; 95% confidence interval [CI], 6.11-8.03) and late preterm preeclampsia (OR, 2.82; 95% CI, 2.38-3.34) in the same pregnancy and weakly associated with term preeclampsia (OR, 1.16; 95% CI, 1.06-1.27), but they were not associated with gestational hypertension (OR, 1.07; 95% CI, 0.92-1.25). Association strengths were consistent across heart defect types. Offspring congenital heart defects in a previous pregnancy were also strongly associated with preterm preeclampsia in subsequent pregnancies (early preterm preeclampsia: OR, 2.37; 95% CI, 1.68-3.34; late preterm preeclampsia: OR, 2.04; 95% CI, 1.52-2.75) but were only modestly associated with term preeclampsia and not associated with gestational hypertension. Similarly, preterm preeclampsia in a previous pregnancy, but not term preeclampsia or gestational hypertension, was associated with offspring congenital heart defects in later pregnancies (early preterm preeclampsia: OR, 7.91; 95% CI, 6.06-10.3; late preterm preeclampsia: OR, 2.83; 95% CI, 2.11-3.79; term preeclampsia: OR, 0.98; 95% CI, 0.88-1.10; gestational hypertension: OR, 1.13; 95% CI, 0.92-1.38). CONCLUSIONS: Linked pathophysiological mechanisms may be involved in some congenital heart defects and preterm preeclampsia. The strong associations across pregnancies support a predominantly maternal origin of effect.
BACKGROUND: Both pregnant women carrying fetuses with heart defects and women with hypertensive disorders of pregnancy often exhibit angiogenic imbalances, suggesting that the same mechanisms are involved in the pathogenesis of the former and the pathophysiology of the latter. We conducted a register-based cohort study to determine whether offspring congenital heart defects are associated with an increased risk of hypertensive disorders of pregnancy and whether the mechanisms driving any association are primarily maternal or fetal. METHODS: Among singleton pregnancies without chromosomal abnormalities lasting ≥20 weeks in Denmark from 1978 to 2011 (n= 1 972 857), we identified pregnancies complicated by offspring congenital heart defects or early preterm preeclampsia, late preterm preeclampsia, term preeclampsia, and gestational hypertension. We used polytomous logistic regression to estimate odds ratios (ORs) for associations between offspring congenital heart defects and maternal hypertensive disorders of pregnancy overall and for specific heart defects. RESULTS: Offspring congenital heart defects were strongly associated with early preterm preeclampsia (OR, 7.00; 95% confidence interval [CI], 6.11-8.03) and late preterm preeclampsia (OR, 2.82; 95% CI, 2.38-3.34) in the same pregnancy and weakly associated with term preeclampsia (OR, 1.16; 95% CI, 1.06-1.27), but they were not associated with gestational hypertension (OR, 1.07; 95% CI, 0.92-1.25). Association strengths were consistent across heart defect types. Offspring congenital heart defects in a previous pregnancy were also strongly associated with preterm preeclampsia in subsequent pregnancies (early preterm preeclampsia: OR, 2.37; 95% CI, 1.68-3.34; late preterm preeclampsia: OR, 2.04; 95% CI, 1.52-2.75) but were only modestly associated with term preeclampsia and not associated with gestational hypertension. Similarly, preterm preeclampsia in a previous pregnancy, but not term preeclampsia or gestational hypertension, was associated with offspring congenital heart defects in later pregnancies (early preterm preeclampsia: OR, 7.91; 95% CI, 6.06-10.3; late preterm preeclampsia: OR, 2.83; 95% CI, 2.11-3.79; term preeclampsia: OR, 0.98; 95% CI, 0.88-1.10; gestational hypertension: OR, 1.13; 95% CI, 0.92-1.38). CONCLUSIONS: Linked pathophysiological mechanisms may be involved in some congenital heart defects and preterm preeclampsia. The strong associations across pregnancies support a predominantly maternal origin of effect.
Authors: Bhavisha A Bakrania; Frank T Spradley; Heather A Drummond; Babbette LaMarca; Michael J Ryan; Joey P Granger Journal: Compr Physiol Date: 2020-12-09 Impact factor: 9.090
Authors: Yasser H Habib; Mennatallah A Gowayed; Sherien A Abdelhady; Nevine M El-Deeb; Inas E Darwish; Mahmoud M El-Mas Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2021-09-01 Impact factor: 3.195
Authors: Camilla Omann; Camilla Nyboe; Rasmus Kristensen; Andreas Ernst; Cecilia Høst Ramlau-Hansen; Charlotte Rask; Ann Tabor; J William Gaynor; Vibeke E Hjortdal Journal: Eur Heart J Open Date: 2022-04-21
Authors: Laura E Coats; Bhavisha A Bakrania; Daniel R Bamrick-Fernandez; Allison M Ariatti; Adam Z Rawls; Norma B Ojeda; Barbara T Alexander Journal: Am J Physiol Heart Circ Physiol Date: 2021-03-19 Impact factor: 4.733
Authors: Jill J Savla; Mary E Putt; Jing Huang; Samuel Parry; Julie S Moldenhauer; Samantha Reilly; Olivia Youman; Jack Rychik; Laura Mercer-Rosa; J William Gaynor; Steven M Kawut Journal: J Am Heart Assoc Date: 2022-01-11 Impact factor: 6.106
Authors: Michelle Kaplinski; Deanne Taylor; Laura E Mitchell; Dorothy A Hammond; Elizabeth Goldmuntz; A J Agopian Journal: PLoS One Date: 2019-05-29 Impact factor: 3.240